Showing results (271-280 of 364) with videos related to

Sort By:
Pageof 37
British Journal of Pharmacology|February 13, 2007
A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptorsR G Vickery, N Mai, E Kaufman, et al.
Current Biology : CB|March 14, 2007
A putative cation channel and its novel regulator: cross-species conservation of effects on general anesthesiaJohn A Humphrey, Kevin S Hamming, Colin M Thacker, et al.
JCO Clinical Cancer Informatics|September 30, 2022
Prediction of Adverse Pathology at Radical Prostatectomy in Grade Group 2 and 3 Prostate Biopsies Using Machine LearningNathan Paulson, Tal Zeevi, Maria Papademetris, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 15, 2008
The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activityD T Beattie, S R Armstrong, J P Shaw, et al.
The Journal of Physiology|November 2, 2002
Excitation of rat colonic afferent fibres by 5-HT(3) receptorsGareth A Hicks, Jonathan R Coldwell, Marcus Schindler, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 15, 2006
Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlationSrinivasa R Prasad, Peter A Humphrey, Jay R Catena, et al.
The American Journal of Pathology|May 14, 2019
Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis PredictorMichael J Hwang, Kelly G Bryant, Jae H Seo, et al.
Journal of Orthopaedic Trauma|July 15, 2024
Primary Closure of External Fixator Pin Sites Is Safe After Orthopaedic Trauma SurgeryJames D Brodell, Brittany Haws, Jeffrey B Shroff, et al.
Urology|September 28, 2002
Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor featuresJason S Krumholtz, Gustavo F Carvalhal, Christian G Ramos, et al.
Pageof 37